A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
for Dry Eye Disease
20 locations incl. Dothan
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07284381·Phase 3·Recruiting